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The invention is directed to novel promoters or mutants 
thereof from Chlorella virus DNA methyltransferase genes. 
A Chlorella virus gene promoter is operably linked to a first 
and/or second DNA sequence encoding a gene that is 
different from the Chlorella virus gene to form an expression 
cassette. An expression cassette can be introduced into 
prokaryotic and/or eukaryotic cells and can provide for a 
high level of expression of the gene encoded by the first 
and/or second DNA sequence. The invention also provides 
a method for screening other Chlorella virus genes for 
promoters that can function to express a heterologous gene 
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1. 
PROMOTERS FROM CHILORELLAVRUS 
GENES PROVIDING FOR EXPRESSION OF 
GENES IN PROKARYOTIC AND 
EUKARYOTIC HOSTS 
This application is a continuation of application Ser. No. 
07/932,334 filed on Aug. 19, 1992 (now abandoned). 
BACKGROUND OF THE INVENTION 
Genetic engineering has provided a method to isolate, 
selectively amplify, and express genes encoding desirable 
traits. These genes are often obtained from one organism and 
transformed into another organism so that expression of the 
gene can be manipulated and maximized. The transfer of 
genes from one organism to another can be used to produce 
large quantities of the gene product as well as to provide the 
transformed organism with improved characteristics or 
traits. Heterologous genes encoding desireable traits can be 
introduced into a wide variety of prokaryotic and eukaryotic 
hosts. For example, advantageous genes encoding herbicide 
resistance from bacteria can be incorporated into a plant's 
genome. The bacterial gene can then be expressed in the 
plant cell to confer on the plant cell resistance to the 
herbicide. 
In order for the newly inserted gene to be expressed in a 
eukaryotic or prokaryotic host cell, proper regulatory 
sequences must be present and in the proper location with 
respect to the gene. These regulatory sequences include a 
promoter region and a 3' nontranslated regulatory region. 
The promoter is a region of DNA sequences located 
upstream from the coding sequence of the gene. The func 
tion of a promoter sequence is to allow access and position 
of the transcription enzyme RNA polymerase in the vicinity 
of the transcription initiation site. The promoter DNA 
sequence can contain regulatory sequence that influence the 
rate and timing of the transcription of the gene. For example, 
insertion of a 21 base pair sequence into the 35S cauliflower 
mosaic virus (CaMV) promoter results in a tissue-specific 
expression in roots (Lam et al., PNAS, 86:7890 (1989).) 
Other sequences, like the TATA box and the CCAAT box in 
eukaryotic promoters, are known to influence the rate and 
level of gene transcription. 
Certain promoters are known to be strong promoters. 
These promoters direct transcription at higher levels than 
other types of promoters and are capable of directing expres 
sions in other types of cells. One of the promoters that is a 
strong promoter in some types of plant cells is the 35S 
cauliflower mosaic virus (CaMV) promoter. However, the 
35S CaMV promoter expression in plants can be variable 
and is especially so in monocotyledonous plants. Thus, 
strong promoters in one system often are not capable of 
providing for gene expression in a wide variety of both 
prokaryotic and eukaryotic host cells. 
Chlorella viruses are a large group of recently identified 
viruses that infect certain eukaryotic green algae Chlorella. 
Chlorella viruses can be produced in large quantities and can 
be assayed by plaque formation. Chlorella viruses are large 
(150 to 190 nm) polyhedral plaque forming viruses contain 
ing greater than 300 kilobases of linear double-stranded 
DNA. The viruses are placed into 16 classes on the basis of 
plaque size antibody reactivity and the nature and abundance 
of methylated bases in their genomic DNA. 
The Chlorella viruses have several unique features. The 
viruses have enough DNA sequence to encode 200 to 300 
proteins. It is known that the virus contains and encodes 50 
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structural genes. The viruses also encode several DNA 
methyltransferase genes, DNA restriction endonuclease 
genes, and DNA polymerase genes. The DNA methyltrans 
ferase genes and the restriction endonuclease genes have 
been studied as a unique DNA restriction-modification sys 
tem. Because the Chlorella viruses can be grown to large 
quantities and have several unique features, they are good 
candidates for the isolation of factors important in gene 
regulation. 
Thus, there is a need for identifying and isolating strong 
promoters that are capable of expressing heterologous genes 
in a wide variety of cell types. There is also a need to identify 
and isolate strong promoters that can function in monocoty 
ledonous plants, like wheat or rice. There is also a need to 
identify, isolate and characterize the promoters of the Chlo 
rella virus genes including the DNA methyltransferase 
genes. 
SUMMARY OF THE INVENTION 
The invention is directed to novel promoters or mutants 
thereof from Chlorella virus DNA methyltransferase genes. 
These novel promoters are operably linked to a first DNA 
sequence encoding a gene that is different from the Chlorella 
virus gene to form an expression cassette. An expression 
cassette can optionally include a 3' nontranslated regulatory 
DNA sequence functional in eukaryotic cells and operably 
linked to the first DNA sequence. The preferred Chlorella 
virus DNA methyltransferase promoters in the expression 
cassette provide for a high level of constitutive gene expres 
sion in prokaryotic and eukaryotic cell hosts. 
An expression cassette of the invention can further com 
prise a second DNA sequence encoding a different gene 
from the first DNA sequence. The second DNA sequence is 
linked to the first DNA sequence and under the control of the 
Chlorella virus promoter. The second DNA sequence pref 
erably encodes a reporter gene or a selectable marker gene. 
An expression cassette of the invention is introduced into 
prokaryotic and eukaryotic cells, preferably in a plasmid 
vector. Plasmid vectors including an expression cassette of 
the invention are used to stably transform prokaryotic cells. 
The preferred transformed prokaryotic species include E. 
coli, phytopathogenic members of the genus Pseudomonas 
and Erwinia, plant associated members of the genux Xan 
thomonas, and members of the genus Agrobacterium. Stably 
transformed prokaryotic cells are selected and are capable of 
transmitting an expression cassette to progeny cells. The 
transformed progeny cells express the genes encoded by the 
first and/or second DNA sequence under the control of the 
Chlorella virus promoters. 
Eukaryotic cells, preferably plant cells, can be trans 
formed with an expression cassette, typically in a binary T. 
vector. Transformed plant cells can transiently express the 
genes from the first and/or second DNA sequence. Trans 
formed plant cells exhibiting transient gene expression, 
preferably monocotyledonous plant cells, can be converted 
to stably transformed or transgenic plants. Transformed 
plant cells are incubated in the presence of callus induction 
medium and a selective agent. Transformed callican then be 
used to generate the transformed or transgenic plants. The 
transgenic plants can be grown and selfed or crossed to 
produce transgenic progeny plants and seeds. The preferred 
transgenic plant of the invention is a monocotyledonous 
plant having a Chlorella virus promoter that provides for a 
high level of constitutive gene expression. 
The invention also provides a method for screening other 
Chlorella virus genes for promoters that can function to 
5,563,328 
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express a heterologous gene in prokaryotic and/or eukary 
otic hosts. Chlorella virus genes and 5' flanking DNA 
sequences are isolated, sequenced, and the coding region of 
the gene identified. Once the Chlorella virus gene and its 5' 
flanking sequence has been identified, a method of the 
invention involves isolating a DNA fragment including 
about 50 to 2000 nucleotide base pairs of the DNA sequence 
upstream from the coding sequence. An expression cassette 
is formed by combining the DNA fragment with a reporter 
gene, like chloramphenicol acetyltransferase. An expression 
cassette is used to transform prokaryotic and/or eukaryotic 
hosts and expression of the reporter gene is detected. Pro 
moter sequences providing for a high level of gene expres 
sion in eukaryotic and/or prokaryotic hosts can be identified. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows expression of AMT-CAT fusion construct 
(ColEI) in various phytopathogenic bacteria. 2 ug of plasmid 
DNA was used to transform bacterial cells by the standard 
calcium coprecipitation method. Chloramphenicol acetyl 
transferase (CAT) assay was performed using 10 ug of total 
protein at 37° C. for 60 minutes to determine the adenyl 
methyltransferase (AMT) promoter activity. The Lanes are 
identified as follows: 1. E. coli, MC1000; 2. E. coli, JM83; 
3. Bacillus pumulis; 4. Erwinia amylovora; 5. Erwinia 
carotovora; P=positive CAT control; and N=negative CAT 
control. 
FIG. 2 shows expression of AMT-CAT fusion construct 
(RK-2) in various phytopathogenic bacteria. 2 ug of plasmid 
DNA was used to transform bacterial cells by electropora 
tion using 6250 V/cm, 25uf capacitor, and Pulse Controller 
at 400 ohms. The Lanes are identified as follows: Clavi 
bacter michiganense ssp. Nebraskense (Lane 1); Pseudomo 
nas syringae pv. syringae (Lane 2); Xanthomonas campes 
tris pv. asclepiadis (Lane 3); and Agrobacterium tumefaciens 
(Lane 4). The positive CAT control is shown in Lane 5 and 
the negative control in Lane 6. 
FIG. 3 shows analysis of promoter activity of AMT-5 
deletion mutants in E. coli MC1000. E. coli competent cells 
were chemically transformed by calcium co-precipitation 
and analyzed for CAT activity. The deletion end points are 
shown at the left. 
FIG. 4 shows expression of AMT-CAT fusion constructs 
in various systems. 35S-CAT expression was used to com 
pare the AMT promoter activity. AMT-CAT and 35S-CAT 
constructs were used to compare the AMT promoter activity. 
AMT-CAT and 35S-CAT constructs were used to electropo 
rate wheat, rice and tobacco cells and to transform compe 
tent E. coli and Agrobacterium cells. Same constructs were 
used in binary vectors for Agrobacterium medicated stable 
transformation of tobacco and Arabidopsis calli. CAT activ 
ity was determined by using 2 pig total protein incubated for 
20 minutes at 37° C. 
DETAILED DESCRIPTION OF THE 
INVENTION 
This invention is directed to novel promoters from Chlo 
rella virus genes that provide for a high level of gene 
expression in prokaryotic and/or eukaryotic cells. A pro 
moter associated with a Chlorella virus gene is isolated and 
operably linked to a DNA sequence encoding a gene differ 
ent from that of the Chlorella virus gene in an expression 
cassette. An expression cassette can be further comprised of 
a 3' nontranslated regulatory DNA sequence functional in 
eukaryotic cells and/or a second DNA sequence encoding a 
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selectable marker gene. An expression cassette can also be 
further comprised of plasmid DNA or a binary T vector 
DNA. The vector so formed can be used to deliver an 
expression cassette to the prokaryotic or eukaryotic cells. 
Transformed bacterial cells, preferably Agrobacterium, 
express high levels of the gene under the control of the 
Chlorella virus gene promoter. Transformed plant cells also 
express the gene or genes controlled by the Chlorella virus 
promoters at high levels and can be used to generate 
transgenic plants. 
1. Formation of an Expression Cassette 
A. Promoters 
The promoters of the invention are obtained or modified 
from Chlorella virus genes. Chlorella viruses are large (150 
to 190 nm) polyhedral plaque-forming viruses containing 
>300 kb of linear double-stranded DNA. At least 37 strains 
of the virus that infect eukaryotic Chlorella-like green algae 
have been isolated and partially characterized. The viruses 
are placed into 16 classes on the bases of plaque size, 
antibody reactivity, and the nature and abundance of methy 
lated bases in their genomic DNA. Each of the viral DNAs 
contains 5-methylcytosine at a percentage of cytosine rang 
ing from 0.1% to 47.5%. In addition, 25 of the 37 viral DNA 
also contain N' methyladenine as a percentage of adenine 
ranging from 1.45% to 37%. The finding of sequence 
specific methylation led to the discovery that these viruses 
have genes encoding DNA methyltransferases and site 
specific endonucleases. In addition, these viruses contain at 
least 50 structural genes. 
Some of the Chlorella virus genes, including the 5' 
flanking regions, have been isolated and sequenced. Four of 
the viral-encoded DNA methyltransferase genes have been 
isolated and sequenced, as reported by Shields et al., Virol 
ogy, 176:16 (1990); Stefan et al., Nucleic Acids Res., 19:307 
(1991); Narva et al., Nucleic Acids Res., 15:9807 (1987); and 
Zhang et al., Nucleic Acid Res. (submitted for publication) 
Two DNA polymerase genes including 5' flanking regions 
from Chlorella viruses PBCV-1 and NY-2A were isolated 
and sequenced, as described by Grabherr et al., Virology, 
188:721 (1992). 
Most genes have regions of DNA sequence that are 
known promoters and which regulate gene expression. Pro 
moter regions are typically found in the flanking DNA 
sequence upstream from the coding sequence in both 
prokaryotic and eukaryotic cells. A promoter sequence pro 
vides for regulation of transcription of the downstream gene 
coding sequence and typically includes from about 50 to 
2000 nucleotide base pairs. Eukaryotic promoters usually 
contain a consensus sequence known as the TATA box 
region, 20-30 base pairs (bp) upstream from the transcrip 
tion initiation site. A second eukaryotic consensus sequence, 
the CCAAT box region, is also found at about 80 bp 
upstream from the transcription initiation site. Prokaryotic 
promoters typically a have a TATAAT consensus sequence 
10 bp upstream from the start codon, and a TTGACA35bp 
upstream from the start codon. These consensus sequences, 
as well as other promoter regulatory sequences, can be 
present and function to regulate levels of gene expression. 
For example, a 21 bp element has been identified in the 35S 
cauliflower mosaic virus promoter as providing for root 
specific gene expression, as described by Lam et al., PNAS, 
86:7890 (1989). 
5,563,328 
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Promoter DNA sequences are found upstream and are 
associated with expression of a particular gene. The gene 
regulated by the promoter sequence can be referred to as the 
native or homologous gene. Some isolated promoter DNA 
sequences can provide for gene expression of heterologous 
gene, that is a gene different from the native or homologous 
gene. Promoter sequences are also known to be strong or 
weak. A strong promoter provides for a high level of gene 
expression, whereas a weak promoter provides for a low 
level of gene expression. An isolated promoter sequence that 
is a strong promoter for heterologous genes has great utility 
and offers many advantages in the transfer of genes from one 
organism to another by recombinant DNA techniques. 
Some of these advantages include providing a sufficient 
level of gene expression to allow for easy detection and 
selection of transformed cells expressing the heterologous 
gene. Another advantage is to replace the native or homolo 
gous promoter with a promoter sequence known to provide 
for a high level of gene expression. A third advantage is to 
allow for the transfer of genes for which a promoter has not 
been identified. 
The promoters of the invention are promoters or mutants 
thereof of Chlorella virus genes. The promoters can provide 
for gene expression in prokaryotic and/or eukaryotic hosts. 
The promoters also provide for gene expression of heter 
ologous genes. A heterologous gene is a gene which is 
different from the Chlorella virus gene from which the 
Chlorella virus promoter is obtained. The heterologous gene 
can be obtained from different organisms, like a bacteria, 
plant or mammal. The promoters of the invention preferably 
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from about 3 to about 150 nucleotides of the coding 
sequence of the Chlorella virus gene from which the pro 
moter is obtained. 
The preferred promoters of the invention are promoters 
that substantially correspond to promoters for Chiorella 
virus DNA methyltransferase genes. A promoter that sub 
stantially corresponds to the promoters for DNA methyl 
transferase genes shares about 85% to 100% DNA sequence 
homology with that promoter while retaining the capacity to 
provide for expression of a heterologous gene. These pro 
moters can preferably function in both prokaryotic and 
eukaryotic cells. The preferred promoters also provide for a 
high level of constitutive expression of heterologous genes. 
The promoter designated AMT-1 is found within about 
850 bp upstream from the adenyl methyltransferase gene 
M.CviBIII from Chlorella virus NC-1A. The promoter des 
ignated AMT 2 is found within about 610 bp from the start 
codon for the adenyl methyltransferase gene M.CviRI from 
Chlorella virus XZ-6E. The promoter sequence designated 
CMT-1 is found within about 500 bp upstream from the start 
codon for the cytosine methyltransferase gene M.CviJI from 
Chlorella virus IL-3A. The adenyl methyltransferase pro 
moters AMT-1 and AMT-2 lack the eukaryotic consensus 
sequences (TATA and CCAAT) and prokaryotic consensus 
sequences (CTATAAT and TTGACA). 
The sequence of the AMT-1 promoter is shown in Table 
I (SEQ. ID No: 1). The sequence of the AMT-2 promoter is 
shown in Table II (SEQ. ID No. 2). The sequence of the 
CMT-1 promoter is shown in Table III (SEQ. ID No. 3). 
TABLE I 
SEQUENCE OF THE AMT-1 PROMOTER 
ATCAGTAATG TGTTAATTGC GAACGCTTGT AATGGTGAAC GAATCCAATT CGGAAATGCA 
GTCGACTACA ATTATTCTTT GACACCTTTG TTGACGACGC ATGCAAAGTT GAATATTGAC 
AATCTCGTAT AAATTATTCG TTTATGCTGT TTCAAATCAT ATTGAAGTTC ACTGGTTTTA 
GAGTGTCGAA AAGTATCATA TCAACGATTA TAGTATTTAA TGACAATACT CGCGACTGTC 
ATAGTTATT TTTCAACAAT GGAGTCTCGT CATCATATCA ATTTGACGAA TGTTGTTCGT 
ATACAAAATA TAACAGATGA TTTTATTTGC GAATACGAAG ATTCTTCTTA TGGAGAAGAA 
CCAGTTAATA ACAAATCGGA AGAAGTTCAT ACAGCGTTCA AATTATATGA CATAGATGAC 
GAAACATTGT ACAATTATTA CAACGGAGTG GTCGTACATA CTACAAATGG ATTGCCAATA 
GTATTCGCAA TGGATACACA CCGAGGTTGT TGCGAGAAAT TTTGTATCAC GGTACAATTA 
CCAGGGGGCC TTACGCGATA TGATTTTATT GGCGCCACGA TTACGAAGGT AAGATTTGGT 
AAAGAAAAAC GCAAATGCGA TATTAATTTT TCGGAATTAA TTATAGAAAC TTCGGTAGGA 
AATATCGTTT TACTGGCAGA AAACATTCAT AATGGATAT ACTCTCATGA TGTATTCGCT 
TGTTTTGAAG GTAAAGTTGA AACTTTTCGT TTGTAAATAC AAAAAATGTA TATGAGTATT 
TGTTGTCGGA ATGTCATATC AACAATGTTG TGTATATATG TGTAAACTAA AATACACTAT 
ATATTATTTA A 
TABLE II 
SEQUENCE OF THE AMT-2 PROMOTER 
GAATTCTACT TATATACCAT ATCATTTTCC ATAACAAATT GAAAGTCGAA TGATTTACCA 
CGTCCTCCGA TTTGTTCTAC GCTCTTCAAT TTTGTAATAT CAATGACATT TGAAATACT 
TCTAACAGTC TCGTTGAAC ACTTGTATTT TCGTTAATAT CACGATTATT TAGTGTATCA 
ACTATAATTT TTCTCGCTGC TTATTGTTAA TATCGTTGTC TCCGCGAATA CCTGTTACGA 
AAATATCATC AGGATTATCC CGTTCCTTTT CAGCAAGTTT TTCCGCCTTT ACTCGTTCCT 
TTTCAGCAAG TTTTTCCGCC TTTACTCGTT CCTTTTCAGC AAGTTTTTCC GCCTTACTC 
GTTCCTTTTC GATTTTGCTA ACCTTTTTCA TTTTCATAAG ATTGATTATG TTATAATAT 
TCAGCATATT TATGTTCTGT TCACATATTA ATATATATAA ATAAAATGAC ACAAAAATGA 
CACAAAAATG ACACAAAAAT GACACAAAAA TGACATAGAA TTTACACTTG TACACTAGAC 
ACGTGTACAC AATATCATAT CAACATACGA AACAACTTAA ATTAAAAAAA ATGATTGATT 
TTATAAAT 
include from about 50 bp to 2000 bp more preferably 500 to 65. 
2000 bp of DNA sequence and can contain regulatory 
sequences. The promoters of the invention can also include 
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TABLE I 
SEQUENCE OF THE CMT-1 PROMOTER 
TGTGATGAAC TTGAGTTTTA CAAAAATATT TCTGGTGGAA CTATATATTA TAGTCCATCA 
GATAAGAATG TCGGATTTGT TATCATTCCC AAGGGTACAG AAGTCCATAT GAAATATGTT 
AATCTTGATC AAGAATGATT GTCATTGTAT ATTTAAACCA TTTATACAAT AAGCGTTGAT 
ATAAGTTTGT ATATACGTCA TTTCGTTATA TCAACAAATG TTATCATATT ATACGTAAAA 
CTGGCTTAAA AAAAAACGAG TGTAACTATA 
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Mutants of the Chlorella virus promoters include those in 
which the DNA sequence has been changed including a 
deletion of nucleotides, insertion of nucleotides, and/or 
substitution of nucleotides. Mutants preferably contain a 
functional fragment of the native Chlorella virus promoter. 
Mutants of the promoters of the Chlorella virus genes can be 
generated by standard methodologies including terminal and 
internal deletion mutagenesis, as described by Mitra et al., 
Molecular Gen. Genetic, 215:294 (1989); insertional 
mutagenesis and site-specific mutagenesis, as described by 
Lam et al., PNAS, 86:7890 (1989). Deletion mutants can be 
generated, usually lacking at least one nucleotide from either 
the 5' or 3' terminal ends of the promoter sequence. Internal 
deletion mutants of the promoter can be lacking at least one 
nucleotide in the internal portion of the promoter sequence. 
The insertional mutants can be generated by adding DNA 
Sequence either synthesized by automated methods or sub 
cloned from another genome and inserted into an intact 
promoter or a 5" or 3' deletion mutant. A mutant promoter 
sequence can also be generated by site-specific mutagenesis 
by insertion of a synthesized oligonucleotide sequence hav 
ing site-specific mutations. The synthetic oligonucleotide 
sequence can be inserted into the promoter at a specific 
restriction endonuclease site. Mutant promoter sequences 
can be tested for the ability to provide for expression of a 
heterologous gene by the method of the invention. 
Deletion mutants removing up to about 300 bp from the 
5' terminus of the AMT-1 promoter are the preferred mutants 
for providing an AMT promoter that selectively functions in 
bacterial cells and does not function in tobacco cells. Other 
deletion mutants generated from the 3' end or internally, as 
well as insertion mutants, can provide for selective expres 
sion in plant cells and tissue specific expression in plants. 
Promoters from Chlorella virus genes are identified usu 
ally in the AT-rich 5' flanking regions of the coding sequence 
of Chlorella virus genes, preferably DNA methyltransferase 
genes. Once identified as a putative promoter sequence, the 
promoter sequence is subcloned by digesting the cloned 
Chlorella gene sequence with restriction endonucleases to 
isolate the promoter region and optionally about 3 to 150 
nucleotides of the Chlorella virus gene coding sequence. 
Mutants of the promoter sequence can be generated as 
described previously. The digested promoter or mutant pro 
moter sequence is operably linked to a promoterless heter 
ologous gene, such as the chloramphenicol acetyltransferase 
gene in a plasmid, and ligated with T. DNA ligase. The 
resulting plasmids are introduced into prokaryotic and/or 
eukaryotic cells. Transformed bacteria or plant cells can be 
selected, preferably for antibiotic resistance. The selected 
bacterial or plant cells are then assayed for expression of the 
heterologous gene under the control of the Chlorella virus 
promoter. 
Other promoters are present in the Chlorella virus 
genomes and can be identified and tested for the ability to 
provide for expression of heterologous genes in both eukary 
otic and prokaryotic cells in a method provided for in the 
invention. For example, DNA polymerase genes from Chlo 
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rella virus PBCV-1 and NY-2A have been isolated and 
sequenced, as described by Grabherr et al., cited supra. The 
cloned gene sequence includes about 160 to 170 nucleotides 
upstream that are AT rich and could function as a promoter. 
This 5' region of the Chlorella virus DNA polymerase genes 
can be isolated by restriction endonuclease digestion and 
subcloned into a ColEI plasmid orbinary Ti vector upstream 
from a promoterless reporter gene, such as chloramphenicol 
acetyltransferase gene. Subcloning this putative promoter 
region immediately upstream from a promoterless reporter 
gene such as chloramphenicol acetyltransferase genes, pro 
vides a method for testing whether the DNA sequence 
having potential promoter activity can function to express a 
heterologous gene in a prokaryotic and/or eukaryotic cell. 
The ColEI plasmids or binary T vectors can be introduced 
into prokaryotic or eukaryotic cells and transformed cells 
can be assayed for expression of the reporter gene, such as 
chloramphenicol acetyltransferase gene. Thus, other puta 
tive Chlorella virus gene promoters can be identified, iso 
lated and tested for the ability to provide for gene expression 
in both prokaryotic and/or eukaryotic cells. 
B. DNA Sequence Encoding a Heterologous Gene 
Different from the Chorella Virus Gene 
An expression cassette is formed by combining one or 
more DNA sequences encoding desired genes with tran 
scriptional and translational regulatory DNA sequences that 
provide for gene expression in a particular cell type. The 
DNA sequences are combined so that the transcriptional and 
translational control regions are operably linked to the DNA 
coding sequence and can function to provide for gene 
expression. When one or more DNA sequences coding for 
genes are combined with a different promoter sequence than 
the native sequence, the resulting product can be called a 
"DNA construct” or a "fused gene'. 
An expression cassette of the invention is formed by 
combining a promoter or mutant thereof from a Chlorella 
virus gene with one or more DNA sequences that encode a 
gene different from the Chlorella virus gene. The DNA 
sequence preferably encodes a gene that provides a desired 
characteristic in a prokaryotic or eukaryotic host. The gene 
can be another Chlorella virus gene, from a prokaryotic or 
a eukaryotic organism. The gene can also serve as a select 
able marker or reporter gene. The desired gene will be 
selected depending upon whether expression is desired in 
prokaryotic cells, eukaryotic cells, or both, and depending 
on the desired trait. 
Specific examples of the types of genes that can form an 
expression cassette of the invention include plant cell genes 
of economic importance, like growth promoter genes, dis 
ease resistance genes, frost and drought tolerance genes, 
herbicide and insecticide resistance genes, and the like. 
Desired bacterial genes include genes of economic impor 
tance for phyllosphere or rhizosphere bacteria associated 
with plants such as genes encoding oxalic acid degradation, 
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genes encoding chitinase, genes encoding lignin degrada 
tion, and genes encoding biosynthesis of phenazine effective 
to control wheat root disease. In phytopathogenic bacteria, it 
is desirable to include genes that encode antisense messages 
for toxin genes that are associated with plant disease such as 
tagetoxin. Other genes encoding antisense messages can be 
selected from those described in Plant Pathogenic Bacteria, 
Klement et al. editors, Proceedings of the 7th International 
conference on Plant pathogenic Bacteria, Part A/Part B 
(1990). Desired eukaryotic genes include genes for peptide 
hormones, growth factors, cytokines, and the like. The DNA 
sequence can also encode a selectable marker gene or a 
reporter gene that provides for selection of the transformed 
prokaryotic or eukaryotic cells. 
The preferred first DNA sequence of the expression 
cassette encodes resistance to a herbicide such as the 5-enol 
pyruvyl-phosphoshikimate gene that encodes resistance to 
the herbicide glyphosate. The preferred first DNA sequence 
for use in transformation of phytopathogenic bacteria 
encodes an antisense expression of pathogenic determinate, 
Such as a toxin. 
An expression cassette of the invention can also include 
a second DNA sequence linked to the first DNA sequence 
and different from the first DNA sequence. The second DNA 
sequence preferably encodes a selectable marker gene or a 
reporter gene. 
Specific examples of selectable marker genes are neomy 
cin phosphotransferase gene, apramycin resistance gene, 
hygromycin 3-phosphotransferase gene, dihydrofolate 
reductase gene, guanine phosphoribosyl transferase gene, 
and the thymidine kinase gene. The second DNA sequence 
can also encode a reporter gene such as chloramphenicol 
acetyltransferase, B-galactosidase, 3-glucuronidase, and 
human growth hormone. 
Once the desired gene is selected, its DNA sequence can 
be isolated from the source organism by standard method 
ologies, as provided in Sambrook et al., Molecular Cloning: 
A Laboratory Manual, Coldspring Harbor Laboratories, 
Cold Spring, N.Y. (1989). Generally, once a desired gene is 
selected, a DNA library is prepared from the source organ 
ism. Clones of DNA having the desired gene are detected by 
a variety of methods, including hybridization to oligonucle 
otide probes or detection of expression of the gene product. 
DNA clones containing the gene can be subcloned and 
sequenced. 
Once sequenced, the portion of the DNA sequence encod 
ing the coding sequence for the gene and lacking a func 
tional native promoter can be combined with Chlorella virus 
promoter in a ColEI plasmid orbinary T vector. Briefly, the 
DNA sequence encoding the gene and the ColeI plasmid or 
the binary T. vector are digested with one or more restriction 
endonucleases and then ligated together with T. DNAligase. 
Resulting plasmids incorporating the desired gene lacking 
all or part of the native promoter are selected and amplified, 
usually in a bacterial host. The plasmid carrying the desired 
gene can then have a Chlorella virus promoter sequence 
inserted upstream so that the promoter is operably linked to 
DNA coding sequence, typically at a different restriction 
endonuclease site. Alternatively, the promoter sequence and 
the DNA sequence encoding the gene can be ligated together 
first and then inserted into a plasmid for selection and 
amplification. 
C. 3" Nontranslated Regulatory Region 
Optionally, when necessary for efficient gene expression, 
the expression cassette can include a 3' nontranslated regu 
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latory DNA sequence. The 3' nontranslated regulatory DNA 
sequence preferably includes from about 3 to 1000 nucle 
otide base pairs (bp) and contains transcription and/or trans 
lation termination sequences. The 3' nontranslated regions 
can be obtained from the flanking regions of genes from 
bacterial, plant, or other eukaryotic cells. For transcription 
efficiency and termination of a first DNA sequence encoding 
a prokaryotic gene, the 3' flanking sequences can include a 
transcription termination sequence. For transcription effi 
ciency and termination of a first DNA sequence encoding a 
eukaryotic gene, the 3' flanking sequence has a polyadeny 
lation sequence that functions to add a polyA tail to the 
messenger RNA. The 3' nontranslated regions are operably 
linked to the first and/or second DNA sequence to provide 
for gene expression in prokaryotic and eukaryotic cells by 
standard methodologies, as described in Sambrook et al., 
cited Supra. 
Specific examples of the 3' nontranslated regulatory DNA 
sequences functional in eukaryotic cells include about 500 
bp of 3' flanking DNA sequence of the pea ribulose biphos 
phate carboxylase small subunit E9 gene, 3’ flanking DNA 
sequence of the octopine synthase gene, the 3' flanking DNA 
sequence of the nopaline synthase gene, and SV40 polyade 
nylation and transcription termination sequences. Especially 
preferred are the 3' nontranslated regulatory DNA sequences 
that function in plant cells such as the 3’ flanking DNA 
sequence from the octopine synthase or nopaline synthase 
genes. 
The 3' nontranslated DNA regulatory regions are often 
already present in plasmid vectors used for selection ampli 
fication and transformation of prokaryotic and eukaryotic 
cells. Typically, the desired first and/or second DNA 
sequence encoding the desired genes are inserted immedi 
ately upstream from 3' nontranslated DNA regulatory 
sequence so that the DNA sequences are operably linked 
together. Alternatively, the 3' nontranslated DNA regulatory 
regions known to be functional in prokaryotic or eukaryotic 
cells can be isolated from a cloned gene sequence by 
restriction endonuclease digestion. Once isolated, the 3' 
flanking region DNA sequence can be inserted downstream 
from the first or second DNA sequence by standard sub 
cloning methods, as described by Sambrook et al., cited 
Supra. 
2. Formation of a Vector Containing the Expression 
Cassette 
Vectors include additional DNA sequences that provide 
for easy selection, amplification, and transformation of the 
expression cassette in prokaryotic and eukaryotic cells. The 
additional DNA sequences include origins of replication to 
provide for autonomous replication of the vector, selectable 
marker genes preferably encoding antibiotic resistance, 
unique multiple cloning sites providing for multiple sites to 
insert the expression cassette, and sequences that enhance 
transformation of prokaryotic and eukaryotic cells. The 
preferred vectors of the invention are plasmid vectors. The 
especially preferred vectors are the ColBI plasmid vector or 
the binary T vector pGA582. 
ColEI plasmid vectors, such as puC18 and pUC19, have 
been previously characterized by Yanisch-Perron et al., 
Gene, 33:103 (1985) and are available from Stratagene or 
New England BioLabs. A ColEI plasmid vector is a 2.7 kbp 
plasmid and contains an origin of replication that provides 
for autonomous replication in both prokaryotic and eukary 
otic cells. A ColEI plasmid also contains selectable marker 
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genes encoding antibiotic resistance. A ColEI plasmid con 
tains multiple cloning sites providing for insertion of an 
expression cassette of the invention. A ColEI plasmid car 
rying an expression cassette of the invention can be used to 
transform both prokaryotic and eukaryotic cells. 
The binary T vector pGA582 has been previously char 
acterized by An, Methods in Enzymology, 153:292 (1987) 
and is available from both Dr. An and Dr. Mitra. The binary 
T vector can replicate in prokaryotic bacteria, such as E. 
coli, and in Agrobacterium. The Agrobacterium plasmid 
vectors can be used to transfer the expression cassette to 
plant cells. The binary T vectors preferably include the 
nopaline T-DNA right and left borders to provide for effi 
cient plant cell transformation, a selectable marker gene, 
unique multiple cloning sites in the T-border regions, the 
ColEI replication of origin, and a wide host range replicon. 
The binary T vectors carrying an expression cassette of the 
invention can be used to transform both prokaryotic and 
eukaryotic cells, but is preferably used to transform plant 
cells. 
A vector of the invention can also include a vector that can 
transform algal cells, including species of Chlorella. For 
example, Jarvis et al., Current Genetics, 19:317 (1991) have 
described the use of plasmid pL)O432 derived from the E. 
coli pUC19 plasmid. This plasmid can contain a reporter 
gene, the nopaline synthase polyadenylation site, and the 
portion of the pUC19 cloning vector (Yanisch-Perron et al., 
Gene, 33:103 (1985)) including the gene for ampicillin 
resistance and an origin of replication. A Chlorella virus 
promoter fused to a gene encoded by the first DNA sequence 
can be introduced upstream from the reporter gene in a 
plasmid such as pl)O432. The plasmid vector can be used to 
transform Chlorella species and other species of green algae. 
A vector of the invention can also be a virus vector. Virus 
vectors can provide for efficient cloning and gene expression 
in both prokaryotic and eukaryotic cells. Specific examples 
of virus vectors of the invention include the M13 phage 
system, the vaccinnia virus expression system, and the 
baculo virus expression system. 
An expression cassette of the invention can be inserted 
into or formed within a plasmid or virus vector by standard 
methods. Briefly, the Chlorella virus promoter or a mutant 
thereof can be combined with the first DNA sequence 
encoding a gene having the desired trait to form a fused 
DNA construct. Optionally, a 3' nontranslated DNA regula 
tory region can also be operably linked to the first DNA 
sequence. The fused DNA construct can then be inserted into 
one of the multiple cloning sites of the plasmid vectors by 
digestion with an appropriate restriction endonuclease and 
ligation with a ligase enzyme. 
Alternatively, each of the DNA sequences in an expres 
sion cassette can be subcloned into the vector separately. For 
example, in a binary T vector having multiple cloning sites, 
a Chlorella virus promoter sequence can be inserted at a 
unique restriction endonuclease site by digestion with that 
restriction endonuclease followed by ligation. A first DNA 
sequence can then be inserted at a different restriction 
endonuclease site immediately downstream from the Chlo 
rella virus promoter sequence. Optionally, and if not already 
present in the vector, a second DNA sequence encoding a 
selectable marker gene can be inserted at another restriction 
endonuclease site downstream from the first DNA sequence. 
In addition, optionally, if not already present, a 3' nontrans 
lated regulatory DNA sequence can be inserted immediately 
downstream from the first or second DNA sequence so that 
the 3' nontranslated DNA sequence is operably linked to the 
first or second DNA sequence. 
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The preferred plasmid of the invention has the character 
istics of the ColEI plasmid carrying an expression cassette 
including the AMT-1 promoter fused to a promoterless 
chloramphenicol acetyltransferase gene. The AMT promoter 
provides for a high level of constitutive gene expression in 
both prokaryotic and eukaryotic cells. This ColEI plasmid 
has been designated pAM-15 and has been deposited with 
the American Type Culture Collection, Rockville, Md. E. 
coli Jim 83 ampR bacteria on Sep. 8, 1992, and given 
Accession No. 69069. 
The especially preferred plasmid has the characteristics of 
a binary T vector carrying the AMT promoter fused to a 
promoterless chloramphenicol acetyltransferase gene and 
also encoding a neomycin phosphotransferase gene. The 
AMT promoter provides a high level of constitutive gene 
expression in plant cells. 
3. Transformation of Prokaryotic and Eukaryotic 
Cells With An Expression Cassette Having a 
Chlorella Virus Promoter 
An expression cassette is introduced into prokaryotic 
and/or eukaryotic host cells to provide those cells with the 
capacity to express the desired gene encoded by the first 
and/or second DNA sequence under control of the Chlorella 
virus promoter. Cells containing an expression cassette and 
expressing the gene or genes encoded by the first and/or 
second DNA sequence are referred to as "transformed cells'. 
Gene expression in transformed cells can be detected by a 
variety of methods including oligonucleotide probe hybrid 
ization to messenger RNA (mRNA), assay for the functional 
activity of the gene product, or detection of the gene product 
by its physical characteristics. Gene expression in trans 
formed cells can be transient or stable. Transient gene 
expression is measured up to about 72 hours after trans 
formed cells carrying the expression cassette are selected 
and identified. While not in any way meant to limit the 
invention, transient expression indicates that the expression 
cassette is transferred into the cells, the first and/or second 
DNA sequence is being transcribed and translated, and that 
the gene products are reasonably stable in the cell. Stable 
transformation is exhibited when the cells have replicated 
and the expression cassette can be shown to have been 
heritably transmitted and expressed in progeny cells or 
organisms. When genes are expressed continuously, gene 
expression is called constitutive. When gene expression is 
turned on and off, gene expression is called inducible. 
An expression cassette of the invention is introduced into 
prokaryotic and eukaryotic cells. The transformed cells can 
be selected and/or assayed for stable and/or transient gene 
expression. 
An expression cassette of the invention is introduced into 
prokaryotic host cells. The expression cassette is preferably 
present in a plasmid vector such as ColEI plasmid vector or 
the binary T vector. The preferred prokaryotic hosts are E. 
coli, phytopathogenic bacteria including members of the 
genus' Pseudomonas and Erwinia, plant associated non 
pathogenic bacteria of the genus Xanthomonas, and mem 
bers of the genus Agrobacterium. Especially preferred bac 
terial hosts are members of the genus Agrobacterium that 
can then be used to transform plant cells. 
An expression cassette can be introduced into bacterial 
hosts by standard methods, preferably by the calcium co 
precipitation method. Transformed cells carrying an expres 
sion cassette in a plasmid can be first selected for antibiotic 
resistance encoded by a selectable marker gene present in 
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the plasmid vector. Colonies resistant to the antibiotic and/or 
transformed cells are analyzed for expression of the gene . 
encoded by the first and/or second DNA sequence by either 
mRNA hybridization, assay of gene product activity, or 
detection of the presence of the gene product. Typically, 
prokaryotic host cells are stably transformed with an expres 
sion cassette and can heritably transmit the expression to the 
progeny cells. 
In a preferred version, phytopathogenic species of the 
genus Pseudomonas and Erwinia are transformed with 
ColEI plasmid vector carrying the AMT-1 promoter fused to 
a promoterless gene such as the chloramphenicol acetyl 
transferase gene. The transformed bacterial cells can be 
selected for antibiotic resistance and then assayed for gene 
expression of the chloramphenicol acetyltransferase gene. 
The chloramphenicol acetyltransferase gene can serve as the 
first or second DNA sequence. When the chloramphenicol 
acetyltransferase (CAT) gene serves as the second DNA 
sequence, CAT activity can be monitored as a reporter gene 
for the selection of transformed cells carrying the Chlorella 
virus promoters fused to a first DNA sequence encoding the 
desired gene. The preferred AMT promoter provides for a 
high level of constitutive gene expression in both E. coli and 
phytopathogenic bacteria. 
In the especially preferred version, a binary T vector 
carrying the AMT-1 promoter fused to CAT DNA constructs 
is introduced into Agrobacterium species from E. coli. The 
binary T vector is transferred into an Agrobacterium species 
having a helper T, plasmid. The host Agrobacterium strain 
and helper T, plasmid can be selected depending on the plant 
species to be transformed. The binary vectors can be trans 
ferred to Agrobacterium species by a triparental mating 
method or direct DNA transfer method as described by An 
et al., Methods in Enzymology, 153:292 (1987). 
Plasmid vectors carrying an expression cassette compris 
ing a mutant of the Chlorella virus promoter fused to a first 
DNA sequence can also be introduced into prokaryotic or 
eukaryotic host cells. Transformed cells can be initially 
selected, preferably by resistance to an antibiotic. Antibiotic 
resistant cells or transformed cells are examined for expres 
sion of the gene encoded by the first and/or second DNA 
sequence. The mutant Chlorella virus promoter sequences 
can provide for selective expression in prokaryotic or 
eukaryotic cells and can also provide for tissue-specific 
expression. The preferred mutants are deletion mutants of 
the Chlorella virus AMT-1 promoters. 
An expression cassette of the invention can be introduced 
into eukaryotic cells, preferably plant cells. An expression 
cassette preferably in a ColEI orbinary T. plasmid vector be 
introduced into eukaryotic cells by direct DNA transfer 
techniques such as protoplasting, electroporation, biolistic 
transformation, and Agrobacterium-mediated transforma 
tion. The preferred plant cells to be transformed include 
corn, rice, wheat, tobacco, and Arabidopsis cells. The espe 
cially preferred cells are from monocotyledonous plants 
such as rice, corn or wheat. 
Other types of eukaryotic cells can also be transformed by 
vectors including an expression cassette of the invention. 
Eukaryotic cells such as yeast can be transformed using the 
calcium phosphate coprecipitation method. A Chlorella virus 
promoter of the invention can also be inserted into other 
vectors useful to transform eukaryotic cells. For example, a 
Chlorella virus promoter can be inserted into viral expres 
sion systems such as vaccinnia virus. Once inserted into 
these expression systems, they can be combined with a DNA 
sequence encoding the desired gene to provide for gene 
expression in eukaryotic cells. 
10 
15 
20 
25 
30 
35 
45 
50 
55 
65 
14 
In a preferred version, a binary T. vector or a ColEI 
plasmid carrying the AMT-1 promoter fused to a reporter 
gene, such as a promoterless chloramphenicol acetyltrans 
ferase gene, is introduced into wheat, corn, rice and tobacco 
cells by electroporation. Transformed plant cells are exam 
ined for transient expression of reporter gene-chlorampheni 
col acetyltransferase gene by detection of the enzymatic 
activity within about 72 hours of transformation. The 
chloramphenicol acetyltransferase gene can be encoded by 
the first or second DNA sequence. When encoded by the 
second DNA sequence, the chloramphenicol acetyltrans 
ferase gene serves as a reporter gene that provides for 
identification of plant cells transformed with the first DNA 
sequence encoding the desired trait and expressed under the 
control of the Chlorella virus promoter. The preferred AMT 
promoter provides for a high level of constitutive gene 
expression in plant cells. 
Transformed plant cells exhibiting transient gene expres 
sion under control of a Chlorella virus promoter or a mutant 
thereof can be cultured to generate stable transformants. 
Stable transformants can be generated by growth on medium 
that induces callus formation. Alternatively, confirmed 
transformants of haploid cell lines, such the wheat cell line 
Pavon 64, can be doubled with colchicine or crossed with 
viable pollen to generate seeds. 
Plants cells, calli or organs can also be transformed by 
Agrobacterium species carrying a binary T vector including 
an expression cassette of the invention. The transformed 
plant cells, preferably tobacco or Arabidopsis, can form calli 
after plant cell growth on calli induction medium over a 
period of about 2 to 4 weeks. Plant organs, such as leaf, 
stem, hypococotyls, and cotyledons, can also be transformed 
by co-cultivation with Agrobacterium species carrying 
binary T vectors. Transformed plant organs can also be 
induced to form calli. The transformed calli are preferably 
grown in the presence of selective agents, such as antibiot 
ics. After the transformed calli are formed and selected, the 
expression of the genes under control of a Chlorella virus 
promoter encoded by the first and/or second DNA sequence 
is detected. The transformed calli exhibit stable transforma 
tion. While not in any way meant to limit the invention, it is 
believed that replication and cell division in the formation of 
calli from the transformed plant cells or organ tissues, 
indicates that the expression cassette is stably integrated into 
the plant cell genome and is replicated and transmitted to 
progeny cells. 
4. Formation of Transgenic Plants 
The transformed plant calli exhibiting stable expression of 
the genes encoded by the first and/or second DNA sequence 
under the control of a Chlorella virus promoter or a mutant 
thereof can be used to generate transgenic plants. Methods 
of generating transgenic plants from calli are described in 
Plant Molecular Biology Manual, Kluwer Publishing 
(1988). Briefly, transformed plant cells are grown on callus 
or shoot induction medium containing an a selective agent, 
typically an antibiotic until calli are formed, generally about 
2-4 weeks. Transformed calli can be induced to form shoots 
in the presence of cytokinin in the medium. Transgenic 
plants can be regenerated after 4-6 weeks of incubation 
from shoot cultures. 
Transgenic plants can be crossed with other transgenic 
and/or nontransgenic plants. The next (F) generation of 
plants can be examined for heritable transmission of an 
expression cassette of the invention. Transgenic progeny 
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plants to which an expression cassette has been inheritably 
transmitted can provide transgenic seeds containing a het 
erologous gene under the control of a Chlorella virus pro 
Oter. 
5. Method of Identifying Whether a Promoter or 
Mutant Thereof a Chlorella Virus Gene Can 
Function to Express a Heterologous Reporter Gene 
The invention also provides a method for identifying 
whether a putative Chlorella virus gene promoter sequence 
or a mutant Chlorella virus gene promoter sequence can 
provide for gene expression of a heterologous gene. A 
heterologous gene is a gene different from the original or 
native Chlorella virus gene. The heterologous gene is pref 
erably a promoterless reporter gene such as chloramphenicol 
acetyltransferase, 3-galactosidase, 3-glucuronidase, or 
human growth hormone. 
In the method of the invention, a DNA fragment is 
isolated from a Chlorella virus gene. Once a Chlorella virus 
gene sequence has been cloned and identified, about 50 to 
2000 nucleotide base pairs upstream from the 5' end of the 
coding sequence of the Chlorella virus gene can be isolated 
by restriction endonuclease digestion. This DNA fragment 
can then be operably linked to a heterologous gene to form 
an expression cassette. 
An expression cassette can be formed by standard meth 
odologies as described previously. Briefly, the DNA frag 
ment encoding the putative promoter region or the mutant 
promoter region can be combined with the heterologous 
gene in vector such as a plasmid as follows. A colEI plasmid 
having multiple cloning sites can be digested with a restric 
tion endonuclease specific for one of the sites. A heterolo 
gous gene such as the promoterless chloramphenicol acetyl 
transferase (CAT) is also digested with the same restriction 
endonuclease. The plasmid digest and the CAT gene are 
mixed and ligated with a ligase enzyme. The colBI plasmids 
carrying the CAT gene are selected and amplified. These 
plasmids are then digested with a restriction endonuclease 
that cleave at a multiple cloning site upstream from the 
newly inserted CAT gene. The DNA fragment containing 
putative Chlorella virus or mutant Chlorella virus promoter 
is mixed with the digested plasmid and ligated with ligase. 
Plasmids having the putative or mutant Chlorella virus 
promoter operably linked to the heterologous reporter gene, 
such as the gene encoding chloramphenicol acetyltrans 
ferase, are selected. 
An expression cassette so formed is transformed into 
prokaryotic or eukaryotic host cells by standard methods. 
The standard methods include calcium coprecipitation, elec 
troporation, biolistic transformation, and the like. The pre 
ferred transformed host cell is E. coli. 
The expression of the heterologous gene can be detected 
by standard methods. Those methods include radiolabelled 
oligonucleotide probe hybridization to host cell mRNA, 
physical detection of the gene product and/or detection of 
the functional activity of the gene product. The detection of 
gene expression indicates that the putative or mutant pro 
moter Chlorella virus gene sequence can function to provide 
expression of a heterologous gene. 
In a preferred version, a putative or mutant promoter DNA 
sequence from a Chlorella virus DNA methyltransferase 
gene is combined with a promoterless reporter gene, such as 
the chloramphenicol acetyltransferase gene, in a colEI plas 
mid. The colEI plasmid is introduced into an E. coli host and 
the expression of the chloramphenicol acetyltransferase 
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gene is evaluated. The expression of the chloramphenicol 
acetyltransferase gene is monitored by detecting the enzyme 
activity of chloramphenicol acetyl transferase in trans 
formed cells. 
EXAMPLE 1. 
Construction of a Vector Containing An Expression 
Cassette Including Promoters from Chlorella Virus 
DNA Methyltransferase Genes Fused with a 
Chloramphenicol Acetyltransferase Gene (CAT) 
Promoters 
A promoter of the invention is obtained or modified from 
a Chlorella virus gene. Chlorella viruses are large (150 to 
190 nm) polyhedral plaque-forming viruses containing >300 
kb of linear double-stranded DNA. At least 37 strains of the 
virus that infect eukaryotic Chlorella-like green algae have 
been isolated and partially characterized, as described in Van 
Etten et al., Microb. Rev, 55:586 (1991). The viruses are 
placed into 16 classes on the bases of plaque size, antibody 
reactivity, and the nature and abundance of methylated bases 
in their genomic DNA. Each of the viral DNAs contains 
5-methylcytosine at a percentage of cytosine ranging from 
0.1% to 47.5%. In addition, 25 of the 37 viral DNA also 
contain N methyladenine as a percentage of adenine rang 
ing from 1.45% to 37%. The finding of sequence specific 
methylation led to the discovery that these viruses have 
genes encoding DNA methyltransferases and site-specific 
endonucleases. In addition, these viruses contain at least 50 
structural genes. 
Some of the Chlorella virus genes, including the 5' 
flanking regions, have been isolated and sequenced. Four of 
the viral-encoded DNA methyltransferase genes have been 
isolated and sequenced, as reported by Shields et al., Virol 
ogy, 176:16 (1990); Stefan et al., Nucleic Acids Res., 19:307 
(1991); Narva et al., Nucleic Acids Res., 15:9807 (1987); and 
Zhang et al., Nucleic Acid Research (submitted for publica 
tion). Two DNA polymerase genes including 5' flanking 
regions from Chlorella viruses PBCV-1 and NY-2A were 
isolated and sequenced, as described by Grabherr et al., 
Virology, 188:721 (1992). 
The gene encoding an adenyl methyltransferase gene 
including 5' and 3' flanking regions from Chlorella virus 
NC-1A was cloned into plasmid pUC8 and expressed in E. 
coli as described by Narva et al., cited supra. Briefly, virus 
NC-1A DNA was purified and a library of Sau3A partial 
digestion products of the NC-1A DNA was prepared in E. 
coli plasmid pUC8 by standard procedures, as described in 
Mariatis et al., Molecular Cloning: A Laboratory Manual, 
Coldspring Harbor, N.Y. (1982). A clone containing the 
M.CviBIII gene, plasmid NC-1A. 14.8 was selected from 
NC-1A DNA library by a procedure originally suggested by 
Mann et al., Gene, 3:97-112 (1978) to clone bacterial 
methyltransferase genes. The restriction endonuclease Sall 
(GTCGAC) and Taq (TCGA) are inhibited by the presence 
of 6-methyl-deoxyadenine in their recognition sequence. 
Since TCGA sequences are methylated by M.CviBIII, 
recombinant plasmids containing an M.CviBIII gene func 
tional in E. coli are resistant to Sal and Taq. These plasmids 
were selected by treating the plasmid library with Sall 
before transforming E. coli. 
Several transformants of two Sal resistant clones were 
obtained when 10 transforming units were digested before 
transformation of E. coli LE392. One clone, pNC-1A.14.8, 
contained a 2.1 kilobase pair (kbp) insert of NC-1A DNA 
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and was resistant to Sal and Taql when propagated in E. 
coli. A restriction endonuclease map of the 2.1 kbp fragment 
indicated a single Ndel site about 1.2 kbp from one end and 
no internal BamHI, BglIV, SstI, and HindIII sites. When 
Southern blots of NC-1A DNA digested with these restric 
tion endonucleases were probed with nick-translated pNC 
1A. 14.8, two Nde fragments and single BamHI, Bgli, Sst, 
and HindIII fragments were identified as expected. Two 
fragments were also present in double digests of Nde plus 
one of each of the other four restriction endonucleases. No 
hybridization to dot blots of host Chlorella NC64A DNA 
was observed. These results indicate that NC-1A Chlorella 
virus contains a single copy of the M.CviBIII gene and that 
the host Chlorella does not contain the gene. 
The DNA sequence of the entire 2.1 kbp fragment con 
taining the M.CviBTI gene was determined by dideoxy 
nucleotide chain termination sequencing method and 
reported by Narva et al, cited supra. A single open reading 
frame (ORF) of 1131 base paris (bp) was identified within 
the functional domain predicted by Tn5 mutagenesis which 
could encode a polypeptide of 377 amino acids with a 
molecular weight of 42,828. It was assumed that the ATG 
codon was the initiation codon for M.CviBIII for two 
reasons: (i) an ochre (TAA) codon immediately precedes 
ATG, and (ii) fusion of the lacZamino terminus at this site 
results in overproduction of M.CviBIII. 
The Tn5 mutagenesis of recombinant plasmids, including 
pNC-1A, 14.8, was performed as described by deBruijn et 
al., Gene, 27:131 (1984). Sites of Tn5 insertion within the 
M.CviBIII gene were mapped with HindIII and HindIII plus 
EcoRI. Insertional inactivation of the M.CviBIII gene was 
determined by testing the Taqi sensitivity of individual 
plasmids containing unique Tn5 elements. 
A 851 bp putative promoter region present in the 5' 
flanking region of the M.CviBI adenyl methyltransferase 
gene was subcloned into either ColBI plasmids or a binary 
T vector. The plasmid NC-1A.14.8 containing the 2.1 kbp 
fragment was digested with HindIII and Dral to excise the 
851 bp region. The promoter region so isolated was desig 
nated the AMT-1 promoter and was placed upstream of a 
promoterless chloramphenicol acetyltransferase (CAT) cod 
ing sequence in the ColEI plasmidor the binary T. vector by 
standard methods, as described in Sambrook et al., cited 
supra. The sequence of the 851 bp promoter designated 
AMT-1 is shown in Table I (SEQ. ID No: 1). 
A second promoter region was obtained from digestion of 
the pNC-1A. 14.8 with HindIII and Xbal. The second pro 
moter fragment also contained the coding sequence for 53 
amino terminal amino acids of the M.CviBIII methyltrans 
ferase protein. The second promoter construct was also 
subcloned upstream from the promoterless CAT coding 
sequence in ColeI plasmids or the binary T vectors. 
The adenine methyltransferase gene M.CviRI from Chlo 
rella virus XZ-6E was cloned and sequenced as described by 
Stefan et al., cited supra. DNA libraries of EcoRI digestion 
products of Chlorella virus XZ-6E DNA were prepared in 
plasmid pBR322 and transformed in E. coli by standard 
methods (Maniatis et al., 1982). 
Potential clones containing the M.CviRI and M.CviPII 
genes were selected from the XZ-6E DNA library. The 
restriction endonuclease PstI (CTGCAG) is inhibited by 6 
methyladenine in the TGCA portion of its recognition 
sequence. Since M.CviRI methylates adenine in TGCA 
sequences, recombinant plasmids containing a M.CviRI 
gene which is expressed in E. coli are resistant to Pst. 
Likewise, clones containing M.CviRII were screened by 
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treating the library with Rsal; Rsal cleaves GTAC but not 
GT"AC sequences. Resistant plasmids were selected by 
treating the XZ-6E plasmid library with either PstI or Rsal 
before transforming E. coli. 
About 100 transformants were obtained after Pst diges 
tion of the partial EcoRIXZ-6E library. Plasmid DNA was 
isolated from 30 individual colonies and tested for resistant 
to Pst I. One clone, named pXZ-6E5.9, contained a 5.9 kb 
insert of XZ-6E DNA and was resistant to Pst and Cvir. 
Plasmid pXZ-6E5.9 was sensitive to three other restriction 
endonucleases, Rsal, Taq, and Hinfl, whereas virus XZ-6E 
genomic DNA was resistance to each of these enzymes. It 
was concluded that pXZ-6E5.9 contains the M.CviRI gene. 
Subclones of plasmid pXZ-6E5.9 were prepared and 
tested for sensitivity/resistant to Pst and CviRI. These 
experiments localized the M.CviRI gene to a 2.1 kb region 
at one end of pXZ-6E5.9; this plasmid was named pXZ 
6E4. 
The entire viral insert DNA in plasmid pXZ-6E. 14 was 
subcloned and sequenced as reported by Stefan, cited supra. 
Two open reading frames (ORF) of 243 (ORF-A) and 1137 
bases were identified. These two ORFs could code for 
polypeptides of 81 (predicted molecular weight of 9,504) 
and 379 (predicted molecular weight of 42,814) amino 
acids, respectively. The larger ORF is the M.CviRI gene 
because the amino acid sequence is similar to other adenine 
methyltransferases. 
The putative promoter region of about 610 pb located 5' 
to the potential start codon of the adenyl methyltransferase 
gene M.Cvir was subcloned into either ColEI plasmids or 
a binary T vector. The plasmid pXZ-6E. 14 containing a 2.1 
kbp fragment was digested with restriction endonucleases 
XhoI and BglII to excise the 610 bp region. The promoter 
region so isolated was designated AMT-2 promoter and was 
placed upstream of a promoterless CAT coding sequence in 
the ColEI plasmid or the binary T. vector by standard 
methods. The DNA sequence of the AMT-2 promoter is 
shown in Table II (SEQ. ID No. 2). 
The cytosine methyltransferase gene M.Cviji from Chlo 
rella virus IL-3A was obtained as described in Shields et al., 
Virology, 176:16 (1990). Briefly, virus IL-3A DNA was 
purified and DNA libraries of Sau3A and Taq partial 
digestion products of IL-3A DNA were prepared in E. coli 
plasmid pUC19 by standard methods (Maniatis et al., 1982). 
Potential clones containing the M.CvijI gene were 
selected from the IL-3A DNA library by a procedure origi 
nally suggested by Mann et al. cited supra. to clone bacterial 
methyltransferase genes. The restriction endonucleases Hin 
dIII (AAGCTT) and SstI (GAGCTC) are inhibited by 5 
methylcytosine in the AGCT portion of their recognition 
sequences. Since M.Cviji methylates cytosine in AGCT 
sequences, recombinant plasmids containing a functional 
M.CviJI gene should be resistant to HindIII and Sst. Resis 
tant plasmids were selected by treating the IL-3A plasmid 
library with both HindIII and Sst before transforming E. 
coli. 
Several transformants were obtained after HindIII and 
Sst digestion of partial Sau3A and Taq IL-3A libraries. 
Plasmid DNA from nine colonies, all from the Sau3A 
library, were resistant to Cvij. These colonies had an insert 
DNA of about 10 kb or 7.2 kb. One of the later colonies 
(named pL-3A.22) was selected for detailed study. As 
expected, pIL-3A.22 DNA was also resistant to Alu and 
sensitive to other enzymes such as Hhal, Thai and HpaII. 
The pIL-3A.22 contains the M.Cviji gene, however, the 
insert DNA also either contains a second cytosine methyl 
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transferase gene or the M.CvijI enzyme is less specific than 
Cvi. 
Subclones of plasmid pL-3A.22 were prepared and tested 
for sensitivity to CvijI and HaeII. These experiments local 
ize the M.CvijI gene and resistance to HaeII to a 3.7 kb 
region at the 3' end of pIL-3A.22. The M.CvijI gene was 
further defined by insertional mutagenesis of pIL-3A.22.8 
with transposon Tn5. Plasmids containing Tn5 insertions 
were assayed qualitatively for M.CviJI directed methyliza 
tion by testing the sensitivity of the plasmid DNAs to CvijI 
as well as Hael. Independent insertions defined a region of 
2kb on pH-3A.22.8 which could encode M.CviJ as well as 
resistance to Hae. 
The entire 3731 bp insert DNA from pIL-3A.22.8 was 
sequenced, as reported by Shields et al., cited supra. Three 
open reading frames of 483, 1101, and 486 bp which could 
code for polypeptides containing 161,367, and 162 amino 
acids, respectively, were identified. The sequence of the 
1101 bp plus flanking sequences is the M.CvijI because (i) 
it is the only ORF located in the region identified by Tn5 
mutagenesis and (ii) it has amino acid motifs similar to those 
of other cytosine methyltransferases. 
The 276 bp putative promoter contained within the 5' 
flanking region of the M.CvijI gene was subcloned upstream 
from the CAT coding sequence in either ColEI plasmids or 
binary T vector. The plasmid pIL-3A.22.8 was digested 
with restriction endonuclease and the promoter region so 
isolated was designated CMT-1 promoter and was subcloned 
into the ColEI plasmid or binary T. vector by standard 
methods. The sequence of CMT-1 promoter is shown in 
Table III (SEQ. ID No. 3). 
The putative promoter regions from the DNA methyl 
transferase genes were isolated and subcloned into ColBI or 
binary T vectors by standard methods, as described by 
Sambrook et al. (1989). Briefly, the promoter DNA 
sequences of the methyltransferase genes and the ColEI or 
binary T, vectors were digested with restriction endonu 
cleases and then ligated with T. DNA ligase. The resulting 
plasmids carrying the putative promoter regions from the 
Chlorella virus methyltransferase genes were selected and 
amplified in E. coli MC1000. 
The ColEI plasmids pUC18 and pUC19 are well charac 
terized plasmid as described in Yanisch-Perron et al., cited 
supra, and can be obtained from Strategene or New England 
Biolabs. The chloramphenicol acetyltransferase gene is a 
well known reporter gene and was obtained in plasmid 
pSVOCAT, as described in Gorman et al., Mol. Cell Biol., 
2:1044-1051 (1982). The chloramphenicol acetyltransferase 
gene coding sequence lacking native promoter sequence was 
subcloned into the ColEI plasmid and the binary T vector by 
standard methods, as described by Sambrook et al., cited 
Supra. 
The binary T. plasmid vector pGA582 was obtained as 
follows. A binary T vector for plant transformation and 
promoter analysis was formed as described by An et al., 
Methods in Enzymology, 153:292 (1987). Binary vectors can 
be manipulated in E. coli and then transferred and main 
tained in Agrobacterium. The plasmid pGA582 is a 13.2 
kbp-long binary vector and is available from Dr. An or Dr. 
Mitra. The plasmid has DNA fragments (about 700 bp) 
containing the nopaline T-DNA right border and a fragment 
(600 bp) containing the nopaline T-DNA left border. There 
are nine unique restriction sites in the T-DNA borders for 
cloning foreign DNA. These are HindIII, Xbal, SacI, Hbal, 
KpnI, Cla, BglII, Scal, and EcoRI. The first seven sites are 
clustered in multiple cloning sites. The vector also contains 
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the ColEI origin of replication. The pGA582 also carries a 
wide host range replicon and tetracycline resistance gene 
allowing for stable maintenance of the plasmid in E. coli and 
Agrobacterium. The promoterless chloramphenicol acetyl 
transferase gene was inserted in place of the 2.7 kb Bgll 
EcoRI endonuclease fragment containing the ColEI replica 
tion and cos site. 
The 1.5 kbp DNA sequence inserted in that site contains 
the CAT gene as well as the plant terminator sequence 
derived from octopine T-DNA transcripts. The putative 
promoter sequences from the Chlorella virus DNA methyl 
transferase genes were inserted upstream from the promot 
erless CAT gene in one of the multiple cloning sites. 
EXAMPLE 2 
Transfer and Expression of Chlorella Virus 
Promoter-CAT Constructs Into Prokaryotic and 
Host Cells 
The ColEI plasmids or the binary T vectors containing 
either the AMT.1, AMT-2, the 5' deleted AMT-1, or the 
CMT-1 promoters fused to the chloramphenicol acetyltrans 
ferase (CAT) gene were introduced into eukaryotic and 
prokaryotic host cells, and the expression of chlorampheni 
col acetyltransferase was measured. 
Prokaryotic host cells selected were E. coli, phytopatho 
genic members of the genus Pseudomonas and Erwinia, and 
Agrobacterium. ColEI plasmids or the binary T vectors 
carrying the Chlorella virus promoter-CAT constructs were 
introduced into bacteria by the calcium coprecipitation 
method or by electroporation method. Transformed bacteria 
carrying promoter-CAT constructs were selected in the pres 
ence of amplicillin or tetracycline. The presence of plasmid 
DNA containing the Chlorella virus promoter-CAT con 
structs in the selected bacteria was verified by alkaline lysis 
DNA miniprep method, as described in Sambrook et al., 
cited Supra. 
Gene expression in the transformed cells was measured 
by quantitating the activity of the gene product of the 
chloramphenicol acetyltransferase gene after 24-48 hours of 
culture. The expression pattern of the AMT-CAT constructs 
was, in some cases, compared to the expression of the 35S 
promoter from cauliflower mosaic virus fused to the 
chloramphenicol acetyltransferase gene. 
Chloramphenicol acetyltransferase is assayed in cell 
extracts in the following reaction mixture: 10–20 ml of cell 
extract, 100 ml of 0.25 M Tris-HM) pH=7.8, 10 ml of 4mM 
acetyl coenzyme A, 50 MCi of 'C) chloramphenicol (57 
mCi/mmol, New England Nuclear). The mixture was incu 
bated at 37° C. for 20 minutes. The reaction was stopped by 
adding 1 ml of ethylacetate. The mixture was centrifuged 
and the ethylacetate was removed by evaporation to dryness. 
The dried pellet was dissolved in 30 ml of ethylacetate and 
run on silica gel thin-layer chromatography (TLC). The TLC 
plate was run in 95% chloroform/5% methanol. An X-ray 
film was exposed to the chromogram overnight and the film 
developed. Radioactive spots migrating with an Rf similar to 
the standard were detected. 
Plasmid pAM-55 was constructed from pGA582 plasmid 
and contains the neomycin phosphotransferase gene and 
tetracycline resistance gene, as described in Mitra and An, 
Mol. Gen. Genetics, cited supra. The promoterless CAT gene 
was subcloned into BamHI restriction endonuclease site. 
The Chlorella virus promoter sequences were not fused with 
the promoterless CAT gene. This plasmid was used to 
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determine whether the CAT structural gene could be driven 
by any other promoter on the plasmid. E. coli MC1000 was 
transformed with pAM-55 by the calcium coprecipitation 
method. No CAT activity was detected in the transformed 
cells indicating that promoterless CAT gene subcloned into 
ColEI plasmids was not expressed without the Chlorella 
virus or 35S cauliflower mosaic virus promoters. 
The pAM-15 plasmid was constructed in a ColEI plasmid 
and contains AMT-CAT DNA fused DNA constructs as well 
as a gene encoding resistance against ampicillin. 2 g of 
plasmid DNA was used to transform bacterial cells by the 
calcium coprecipitation method. The bacteria transformed 
were E. coli and phytopathogenic bacteria from the genes 
Erwinia and Bacillus. The results are shown in FIG. 1. Lane 
1 corresponds to E. coli MC1000; Lane 2 corresponds to E. 
coli JN83; Lane 3 corresponds to Bacillus pumulis, Lane 4 
corresponds to Erwinia amylovora; and Lane 5 corresponds 
to Erwinia carotovora; P corresponds to positive CAT 
control; and N corresponds to negative CAT control. 
The results show that the AMT-1 promoter provided for 
high level of constitutive expression of the chloramphenicol 
acetyltransferase gene in E. coli and in some species phy 
topathogenic species of Erwinia. No expression was 
detected in Bacillus pumulis. 
The pAM-50 plasmid was constructed from pGA582 
plasmid, and contained the neomycin phosphotransferase 
gene and tetracycline resistance gene. The Chlorella virus 
AMT promoter fused to CAT construct was also present. 2 
ug of plasmid DNA was used to transform bacterial cells by 
electroporation. The results are shown in FIG. 2. The bac 
terial cells includes Clavibacter michiganense ssp. 
Nebraskense (Lane 1); Pseudomonas syringae pv. Syringae 
(Lane 2); Xanthomonas campestris pv. asclepiadis (Lane 3); 
and Agrobacterium tumefaciens (Lane 4). The positive CAT 
control is shown in Lane 5 and the negative control in Lane 
6. 
The results show that the Chlorella virus AMT promoter 
could be expressed in a phytopathogenic bacterial species 
Pseudomonas Syringae pv. Syringae, as well as Agrobacte 
rium tumefaciens. Thus, the AMT promoter is functional in 
a wide variety of bacterial species, making this promoter 
useful in cloning and expressing heterologous genes in 
different bacterial species. 
EXAMPLE 3 
Analysis of Promoter Activity of AMT-5' Deletion 
Mutants 
Promoters have regulatory regions that are essential to 
regulate levels of expression and tissue-specific expression. 
Mutations of promoter regions can significantly change 
promoter function, including tissue-specific promoter 
expression patterns. Mutant promoter DNA sequences can 
be obtained by known methods of deletion mutagenesis, 
insertional mutagenesis, or site-specific mutagenesis, or 
combinations thereof as described by Lam et al., PNAS, 
86:7890 (1989) and Ha et al., PNAS, 85:8017 (1988). 
Promoter region deletion mutants were generated as 
described by Ha et al., cited supra. Plasmids PUC18 and 
PUC19 are plasmids that are obtained and have the charac 
teristics as described Yanisch-Perron et al., Gene, 33:103 
(1985) (SEQ. ID NO: 4). A synthetic nucleotide (GGTAC 
CTCGAGGCCT) containing restriction sites for KpnI, 
XhoI, StuI was inserted into puC18 and puC19 plasmids in 
a unique SspI site upstream of the B-lactamase gene. The 
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SmaI-Dral fragment containing the AMT-1 promoter region 
of the adenyl methyltransferase gene was then inserted into 
the HindIII site within the Laczo-complementation gene of 
the pUC18 and puC19 plasmids. The plasmids were the 
starting materials for generating 5' and 3' deletion mutants. 
The resulting plasmids were linearized with HindIII and 
digested with an exonuclease, BAL-31, in solution (600mM 
NaCl/12 mM CaCl2/12 mM MgCl/20 mM Tris-HCl, 
pH=8.0) at 30° C. The reaction was stopped at 1-minute 
intervals by removing a portion of the mixture and adding it 
into an Eppendorf test tube containing 0.1 ml of a 0.3M 
sodium acetate (pH=7.0), 0.1 ml chloroform, and 0.1 ml 
phenol. After mixing vigorously, the test tube was centri 
fuged for 2 minutes and the aqueous phase was precipitated 
with 2 vol of ethanol. DNA was dissolved in 10 ml of 
medium-salt buffer (50 mM NaCl/10 mM MgCl/50 mM 
Tris-HCl, pH=8.0), digested with StuI, and self-ligated with 
T4 DNA ligase. Ligated DNA was introduced into E. coli 
MC1000 and the 5' deletion mutants were analyzed by 
digesting DNA prepared from the amplicillin resistant colo 
nies with XhoI and HindIII. The 3' deletion mutants can be 
generated in a similar manner but by placing the synthetic 
oligonucleotide linker downstream from the promoter 
region. 
Using these methods, three 5' deletion mutants were 
isolated and characterized. The deletion end points were 
determined by the Maxam-Gilbert DNA sequencing method 
after labelling the deletion end point with o'P dGTP and 
DNA polymerase large fragment. The 5' deletion mutants 
generated were lacking 304,529 and 753 nucleotide base 
pairs from the 5' end of the AMT-1 promoter. The 5' deletion 
mutants were then fused with the CAT gene and subcloned 
into ColEI plasmids or the T, binary vectors, as described 
previously. 
The three 5' deletion mutants of the AMT promoter were 
used to transform competent E. coli cells by the calcium 
coprecipitation method and analyzed for CAT activity. The 
results are shown in FIG. 3. 
The deletion endpoints of the 5' deletion mutants are 
shown to the left. The deletion end points are measured from 
the translational start codon. The first nucleotide to the left 
of the start codon is designated -1. The AMT promoter 
mutants lacking 304 nucleotides from the 5' end of the 
AMT-1 promoter were functional in E. coli. The AMT 
promoter mutants lacking 525 nucleotides (-325) and 753 
nucleotides (-101) did not provide for CAT expression in E. 
coli. 
The same 5' deletion mutants of the AMT promoter were 
also evaluated for expression in tobacco calli. Suspension 
culture tobacco cells were transformed with 5' deletion 
mutants and transformed calli were analyzed for CAT activ 
ity. The results indicate that only the full length promoter 
(-851) was functional in tobacco calli. 
The analysis of the 5' deletion mutants indicates that for 
some hosts removal of a portion of the AMT-1 promoter 
sequence did not impair the function of the promoter. The 
expression of one of the 5' deletion mutants (-550) in E. coli 
and not in tobacco cells suggests that mutants of the AMT 
promoters can be generated that are selectively expressed in 
certain host cell types. 
EXAMPLE 4 
Stable and Transient Expression of Chlorella Virus 
Promoters in Eukaryotic and Prokaryotic Cells 
Plasmids containing the AMT-CAT expression cassette 
were used to transform rice, wheat, tobacco, and Arabidop 
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sis cells. Tobacco and Arabidopsis cells were cultured for the 
development of transformed calli. The expression of CAT 
driven by the AMT promoters was compared to the expres 
sion of CAT driven by the 35S promoter from cauliflower 
mosaic virus (CaMV). Transient expression of CAT was 
measured after 24-48 hours of culture of the transformed 
cells. Stable expression of CAT was measured in tobacco 
and Arabidopsis calli, Agrobacterium tumefaciens, and E. 
coli. 
Wheat, rice and tobacco cells were transformed with 
plasmids containing the AMT-CAT expression cassette or 
the 35S CaMV promoter-CAT expression cassette. ColEI 
plasmids containing the expression cassettes were intro 
duced into the plant cells by electroporation. Transient CAT 
activity was measured in the transformed plant cells after 
24-48 hours. The results are shown in FIG. 4. 
The AMT promoter provided for a high level of transient 
expression in wheat, rice and tobacco cells. The level of 
expression was higher than that seen with the 35S CaMV 
promoter-CAT constructs. Similar experiments were done 
with the CMT-1 promoter-CAT expression cassette and the 
results also indicated that the CMT-1 promoter could func 
tion to provide for gene expression in the plant cells (data 
not shown). 
For analysis of stable transformation, tobacco and Arabi 
dopsis cells were transformed with Agrobacterium carrying 
a binary T vector and cultured for the development of calli. 
Agrobacterium tumefaciens was transformed using the 
binary T vectors carrying the Chlorella virus AMT promoter 
fused to CAT or the 35S CaMV promoter fused to CAT. 
Tobacco leaf discs and Arabidopsis cells were co-cultivated 
with Agrobacterium carrying the binary T vectors. 
After co-cultivation for two days at 28 C., the bacterial 
cells were washed out and the tobacco leaf discs and 
Arabidopsis cells were grown on callus induction medium 
containing 200 g of kanamycin and 250 pg/ml of carbeni 
cillin. The co-cultivated plant tissues were incubated in the 
dark for callus induction. 
Once transformed tobacco and Arabidopsis calli were 
formed and selected, expression of the AMT-CAT constructs 
was measured in plant extracts as described in Example 2. 
Plant extracts were obtained by lysis of calli with a pestle or 
by Sonication in plant extraction buffer (0.5 molar sucrose, 
0.1% ascorbic acid, 0.1% cysteine-HCl, 0.1 molar Tris-HCl, 
pH-7.8). The lysate was centrifuged and the supernatant 
assayed for chloramphenicol acetyltransferase. The results 
are shown in FIG. 4. 
The results in FIG. 4 show that in both transformed 
tobacco and Arabidopsis calli, the AMT promoter chloram 
phenicol acetyl transferase fused gene was strongly 
expressed. The levels of expression were greater than that of 
the 35S cauliflower mosaic virus chloramphenicol acetyl 
transferase constructs. Thus, the AMT promoter provides for 
high level of transient as well as stable gene expression. 
Tobacco and Arabidopsis calli transformed with an 
expression cassette containing Chlorella virus AMT pro 
moter fused to CAT were used to regenerate transformed 
plants. The transformed or transgenic plants, as well as the 
F1 generation of the transformed plants were analyzed for 
CAT expression. Both transformed plants and the F1 gen 
eration exhibited strong expression of the chloramphenicol 
acetyltransferase gene indicating that the AMT promoter 
CAT constructs can be stably transmitted and expressed 
from generation to generation. 
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EXAMPLE 5 
Formation of Chlorella Virus AMT-Neomycin 
Phosphotransferase Gene and Hygromycin 
Resistant Gene Expression Cassettes and 
Transformation of Wheat 
The AMT promoters were combined with promoterless 
chloramphenicol acetyltransferase (CAT) gene, as described 
in the previous Examples. The expression of this “reporter' 
gene allowed for a standardized measurement of gene 
expression in a variety of cell types. The AMT promoters 
were also combined with genes known to be plant selectable 
markers. One of the genes is known as neomycin phospho 
transferase gene II and is known to encode resistance of 
plant cells to G-418. 
The neomycin phosphotransferase gene is present in the 
binary T vector obtained as described in Example 1. A 
promoterless neomycin phosphotransferase gene was 
obtained by restriction endonuclease digestion of the 
pGA582 plasmid and inserted downstream from the AMT 
promoter in the ColEI plasmid by standard methods. Like 
wise, a promoterless hygromycin resistance gene can be 
subcloned into the ColEI plasmid downstream from the 
AMT promoter using standard methods provided in Sam 
brook et al., cited supra. 
The haploid wheat cell line, Pavon 64, was transformed 
with the fused AMT promoter-neomycin phosphotransferase 
gene. Pavon 64 calli were partially treated with 0.1% 
pectolyase Y-23 and 1% cellulase RS. The cells were elec 
troporated with 25 ug of plasmid ColEI DNA and 75 pig 
carrier DNA at 400 volts with a capacitance of 800 UFD. 
The electroporated cells were grown on 85D12 regeneration 
medium without any plant growth regulators as described by 
Liang et al., CropSci., 27:336 (1987). 
Transformed cells were assayed for neomycin phospho 
transferase activity to detect expression of neomycin phos 
photransferase gene. Neomycin phosphotransferase was 
assayed by standard methods. Briefly, 10ul of plant extract, 
10 ul of assay buffer (40 mM magnesium chloride, 40 mM 
ammonium chloride, 2 mM dithiothreotal, 65 mM Tris-HCl, 
pH=7.5), 2 ul of Kanamycin sulfate and 10 ul of ATP 
solution (50 um ATP and 0.1 mCiPATP, 3000 Ci/mmol) 
was mixed and incubated for 20 minutes at 37° C. The 
solution was spotted onto 1 cm of Whatman P-81 phos 
phocellulose paper and dried under aheat lamp. The spotted 
Whatman paper was washed and then counted in a scintil 
lation counter. 
The results of transformation of the wheat cell line with 
the AMT neomycin phosphotransferase expression cassettes 
show that transient gene expression was obtained in the 
embroyides 36 hours after the electroporation. Thus, the 
wheat cells were transformed and could express the neomy 
cin phosphotransferase gene under the control of the Chlo 
rella virus AMT promoters. 
Stable transformation of wheat plants will be tested by the 
following method. Hygromycin or Kanamycin resistant 
transgenic wheat plants will be doubled with colchicine or 
crossed with viable pollen to produce seeds as described in 
Liang et al., Crop. Sci., 27:336-339 (1987). Seeds will be 
grown and the F1 plants tested for neomycin phosphotrans 
ferase gene expression or hygromycin resistance. 
The references are incorporated by reference. The inven 
tion has been described with reference to various specific 
and preferred embodiments and techniques. However, it 
should be understood that many variations and modifica 
tions may be made while remaining within the spirit and 
scope of the invention. 
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( . ) GENERAL INFORMATION: 
( i i i NUMBER OF SEQUENCES: 4 
( 2) INFORMATION FOR SEQID NO:1: 
( 
5,563,328 
SEQUENCE LISTING 
) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 851 base pairs 
(B) TYPE: nucleic acid 
( C ) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
( i i ) MOLECULETYPE: DNA (genomic) 
( v i ) ORIGINAL SOURCE: 
(A) ORGANISM: Chlorella virus NC-1A 
( v i i ). IMMEDIATESOURCE: 
(B) CLONE: AMT. 
( x i ) SEQUENCE DESCRIPTION: SEQID NO:1: 
AT CA GT AAT G 
GT CGA CT ACA 
AAT C T C G T AT 
GA G T G T C GAA 
ATA GT TAT 
ATA CAA AAT A 
C CA GT TAATA 
GAAA CATT GT 
GTATT C G CAA 
C CA. GGG G GCC 
AAAGAAAAAC 
AAT ATC GTTT 
T GT TTGAAG 
GT T G T C G GA 
AT AT TAT TT A 
T G T TAA TT GC 
AT TAT T C T TT 
AAA TAT T C G 
AAG TAT CATA 
TTT CAA CAAT 
TAA CAGAT GA 
A CAAATCG GA 
A CAATT ATTA 
TGGA TACA CA 
TTA CGC GATA 
G CAAA T G CGA 
TAC GG CAGA 
GT AAA GT T GA 
A T G T CAT ATC 
A. 
( 2) INFORMATION FOR SEQID NO:2: 
( 
GAA CGC TT GT 
GA CA cc TTT G 
TT TAT G. CTGT 
T CAA CGATA 
GGA GT C T C GT 
T TT TATT T. GC 
A GAA GT T CAT 
CAACGGA GT G 
CCGAG GT T G 
T GATTT TATT 
TATAATTTT 
AAA CATT CAT 
AACT TTT CGT 
AACAA T G T T G 
) SEQUENCE CHARACTERISTICS: 
( A ) LENGTH: 609 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: single 
(D) TOPOLOGY: liricar 
( i i ) MOLECULETYPE: DNA (genomic) 
( v i ) ORIGINAL SOURCE: 
( A ) ORGANISM: Chlorca virus XZ-6E 
( v i i ). IMMEDIATE SOURCE: 
( x 
(B) CLONE: AMT-2 
) SEQUENCE DESCRIPTION: SEQED NO:2: 
AA T G G T GAA C 
TT GA CGA C GC 
TT CAAAT CAT 
A GTATTT AA 
CAT CATAT CA 
GAA TAC GAA G 
A CAGC GT T CA 
GT C G T A CATA 
T G CGAGAAAT 
GGC GC CAC GA 
T C G GAAT TAA 
AA T G GAA TT 
T G T AAA. TAC 
T G T A TAATG 
GAA. T C CAA 
A T G CAAA GTT 
ATTGAA GTTC 
TGACAAT ACT 
A TTT GA CGAA 
AT T. CTT CTTA 
AA TATAT, GA 
CTA CAAATGG 
TTT G T AT CAC 
TAC GAAG GT 
T TAT AGA AAC 
A CTCT CAT GA 
AAAAAA T G T A 
T G T AAA CTA A 
26 
CG GAA. A T G CA 
GAA TAT GAC 
A CT GGTTTA 
CGC GAC T G T C 
T G T T G T T C GT 
TGG A GAA GAA 
CAT AGAT GAC 
A T G CCAA TA 
G G TACAATTA 
A. A. GATT G GT 
TT C G GT AG GA 
T G T A TT CGCT 
TAT G A GTATT 
AAT ACA CTAT 
GAA TT CT ACT TATATA C CAT AT CATTTTCC AT AA CAAATT GAAA GT C GAA T GATT TAC CA 
CGT C C T C CGA TTT GTT CTA C GCT. CTT CAAT TTT G T AAT AT CAA T G A CATT T. GAAAT ACT T 
T CTA ACA GT C T CT GTTGAAC ACT T G T A TTT T C GT TAAT AT CAC GATT ATT TA G T G T AT CA 
6 O 
2 O 
80 
2 4 O 
3 O O 
3 60 
4 20 
4. 80 
5 4 O 
6 O O 
6 6. 0 
7 20 
8 O 
8 40 
85 1 
6 
1 2 O 
1 80 
A CTATAATTT 
AAA TAT CATC 
TTT CAG CAAG 
GT T C C T TTT C 
T CAG CATA TT 
CA CAAA AA T G 
A C G T G TA CAC 
T TATAAA TT 
27 
TT CT CGCT GC 
A G GATE ATCC 
TTTTT C C GCC 
GATTTT G CTA 
TA T G T TCT GT 
A CA CAAA AAT 
AAT ATCATAT 
( 2) INFORMATION FOR SEQID NO:3: 
( 
T TAT T G T TAA 
C GT T C CTTTT 
TTT ACT C GT T 
A CCTTTTT CA 
T CACAATA 
GA CA CAAAAA 
CAA CATA CGA 
) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 270 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
( i i ) MOLECULETYPE: DNA (genomic) 
( w i ) ORIGINAL SOURCE: 
(A) ORGANISM: Chlorelia virus IL-3A 
( v i i ). IMMEDIATE SOURCE: 
(B) CLONE: CMT-1 
( x i ) SEQUENCE DESCRIPTION: SEQID NO:3: 
T G T G AT GAA C 
GA TAAGAATG 
AAT CTTGATC 
ATA AG TTT GT 
C T G GCTT AAA 
TT GA GTTTTA 
TCG GATTT GT 
A. A GAA T GATT 
ATA TAC GT CA 
AAAAAA CGAG 
( 2) INFORMATION FOR SEQID NO:4: 
( 
CAAA AAT ATT 
TATCATT C C C 
GT CAT T G TAT 
TT T C GT TATA 
T G T AACTATA 
) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 15 base pairs 
(B) TYPE: nucleic acid 
(C)STRANDEDNESS: single 
(D) TOPOLOGY: linear 
( i i ) MOLECULETYPE: cDNA 
( v i i ). IMMEDIATE SOURCE: 
(B) CLONE: Multirestriction site oligonucleotide 
( x i ) SEQUENCE DESCRIPTION: SEQID NO:4: 
GG T A C C T C GA GGC CT 
What is claimed: 
1. A seed comprising, 
(a) chlorella virus DNA methyltran?ferase gene promoter 
selected from the group consisting of: 
(i) AMT-1, 
(ii) AMT2, 
(iii) CMT-1 
(b) wherein said promoter is operatively joined to a DNA 
sequence of interest not naturally associated with said 65 
promoter. 
2. A plant grown from the seed of claim 1. 
5,563,328 
-continued 
TAT CGT T G T C 
C. A G CAA GTTT 
CCTT TT CAG C 
TTTT CAAA G 
A TATATATA A 
TGA CAT AGAA 
AA CAA CTTA A 
T CTG G T G GAA 
AAG G GTA CAG 
A TTAAA C CA 
T CAA CAAATG 
55 3. A plant expressing a DNA sequence operatively joined 
to a chlorella virus DNA methyltranferase gene promoter 
selected from the group consisting of: 
T C C GC GAAT A 
T T C C GCCTTT 
AA GTTTTTCC 
A TT GATTATG 
ATAAAA T GAC 
TT TACA CTTG 
ATT AAAAAAA 
CTATA ATTA 
AA GT C CATAT 
TT TATA CAAT 
T TAT CATA TT 
(i) AMT-1, 
60 (ii) AMT2, 
(iii) CMT-1. 
4. A cell from the plant of claim 2 wherein said cell 
includes said promoter. 
comprising: 
28 
CCT G T TA CGA 
A CTC GT T C CT 
GCCTTT ACT C 
TT TATAA TAT 
A CAA AA A T G A 
A CACA GAC 
A GATT GATT 
TA GT C CAT CA 
GAA ATA T G TT 
AAGC GT T G AT 
ATAC GT AAAA 
2 40 
3 O 0 
3 60 
4 20 
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60 
20 
8 O 
24 O 
2 T 0 
15 
5. A tissue culture from the plant of claim 2 wherein said 
tissue culture includes said promoter. 
6. A method of expressing a DNA sequence in a plant, 
5,563,328 
29 30 
(a) transforming a cell or a tissue culture so as to contain (b) regenerating a whole plant from said cell or tissue 
a chlorella virus DNA methyltranferase gene promoter culture, and (c) expressing the product encoded by said DNA sequence 
selected from the group consisting of: not naturally associated with said promoter. 
(i) AMT-1, 5 7. A plant transformation vector comprising a chlorella 
(ii) AMT-2, virus methyltranferase gene promoter of claim 1 operatively 
(iii) CMT-1; joined to a DNA sequence not naturally associated with said 
promoter. 
operatively joined to a DNA sequence not naturally associ 
ated with said promoter, ck k k k 
